Judith Schaffrath

Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

Esther Schuler, Eva‐Maria Wagner‐Drouet, Salem Ajib et al. · Annals of Hematology · 2020 · 65 citations · Full text

Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial

Matthias Stelljes, Jan Moritz Middeke, Gesine Bug et al. · The Lancet Haematology · 2024 · 44 citations · Full text

Postmortem age estimation via DNA methylation analysis in buccal swabs from corpses in different stages of decomposition—a “proof of principle” study

Barbara Koop, F. Mayer, Tanju Gündüz et al. · International Journal of Legal Medicine · 2020 · 39 citations · Full text

Value of Different Comorbidity Indices for Predicting Outcome in Patients with Acute Myeloid Leukemia

Maxi Wass, Friederike Hitz, Judith Schaffrath et al. · PLoS ONE · 2016 · 35 citations · Full text

Mixed-phenotype Acute Leukemia, Prognosis, Pretreatment Comorbidities +20

High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group

Judith Schaffrath, Christina Brummer, Daniel Wolff et al. · Transplantation and Cellular Therapy · 2022 · 26 citations · Full text